UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complement activation in IgA nephropathy

Seminars in immunopathology, 2021-10, Vol.43 (5), p.679-690

2021

Volltextzugriff (PDF)

C3 Glomerulopathy: Clinicopathologic Features and Predictors of Outcome

Clinical journal of the American Society of Nephrology, 2014-01, Vol.9 (1), p.46-53

2014

Volltextzugriff (PDF)

The complement factor H-related proteins

Immunological reviews, 2016-11, Vol.274 (1), p.191-201

2016

Volltextzugriff (PDF)

Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy

Kidney international reports, 2023-12, Vol.8 (12), p.2754-2764

2023

Volltextzugriff (PDF)

Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin–Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H–Related Protein-5 (FHR5) Deposition

Kidney international reports, 2018-03, Vol.3 (2), p.426-438

2018

Volltextzugriff (PDF)

Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease

Frontiers in immunology, 2021-04, Vol.12, p.671052-671052

2021

Volltextzugriff (PDF)

Circulating complement factor H–related proteins 1 and 5 correlate with disease activity in IgA nephropathy

Kidney international, 2017-10, Vol.92 (4), p.942-952

2017

Volltextzugriff (PDF)

O - and N -Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10), p.2455-2465

2021

Volltextzugriff (PDF)

New Insights into Epidemiology and Outcome of Bacterial Infection-Related Glomerulonephritis

Clinical journal of the American Society of Nephrology, 2021-08, Vol.16 (8), p.1149-1151

2021

Volltextzugriff (PDF)

Glomerular Complement Factor H–Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment

Kidney international reports, 2019-10, Vol.4 (10), p.1387-1400

2019

Volltextzugriff (PDF)

Circulating complement factor H–related protein 5 levels contribute to development and progression of IgA nephropathy

Kidney international, 2018-07, Vol.94 (1), p.150-158

2018

Volltextzugriff (PDF)

Complement and kidney disease, new insights

Current opinion in nephrology and hypertension, 2021-05, Vol.30 (3), p.310-316

2021

Volltextzugriff (PDF)

Can Urinary Complement Proteins Stratify Patients to Therapeutic Complement Inhibitors?

Kidney international reports, 2022-05, Vol.7 (5), p.939-941

Medjeral-Thomas, Nicholas R.

2022

Volltextzugriff (PDF)

Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis

Kidney international, 2019-03, Vol.95 (3), p.655-665

2019

Volltextzugriff (PDF)

Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence

Nature communications, 2022-12, Vol.13 (1), p.7775-7775, Article 7775

2022

Volltextzugriff (PDF)

Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis

Clinical journal of the American Society of Nephrology, 2022-07, Vol.17 (7), p.994-1007

2022

Volltextzugriff (PDF)

Cohort Study of Outpatient Hemodialysis Management Strategies for COVID-19 in North-West London

Kidney international reports, 2020-11, Vol.5 (11), p.2055-2065

2020

Volltextzugriff (PDF)

Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome

Clinical journal of the American Society of Nephrology, 2014-03, Vol.9 (3), p.478-483

2014

Volltextzugriff (PDF)

Complement in IgA Nephropathy: The Role of Complement in the Pathogenesis, Diagnosis, and Future Management of IgA Nephropathy

Advances in chronic kidney disease, 2020-03, Vol.27 (2), p.111-119

2020

Volltextzugriff (PDF)

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis

Ophthalmology (Rochester, Minn.), 2015-06, Vol.122 (6), p.1262-1268

2015

Volltextzugriff (PDF)

The role of complement in IgA nephropathy

Molecular immunology, 2019-10, Vol.114, p.123-132

2019

Volltextzugriff (PDF)

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Nephrology, dialysis, transplantation, 2019-01, Vol.34 (1), p.63-73

2019

Volltextzugriff (PDF)

5514 IGA NEPHROPATHY: A REAL-WORLD COMPARISON BETWEEN DISEASE SEVERITY, SYMPTOM BURDEN, AND TREATMENT SATISFACTION REPORTED BY PATIENTS AND NEPHROLOGISTS

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Long-Term Outcomes of Patients Treated With Tacrolimus as First Line Therapy for Minimal Change Disease: FR-PO660

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.503-503

2022

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complement activation in IgA nephropathy

C3 Glomerulopathy: Clinicopathologic Features and Predictors of Outcome

The complement factor H-related proteins

Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy

Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin–Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H–Related Protein-5 (FHR5) Deposition

Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease

Circulating complement factor H–related proteins 1 and 5 correlate with disease activity in IgA nephropathy

O - and N -Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function

New Insights into Epidemiology and Outcome of Bacterial Infection-Related Glomerulonephritis

Glomerular Complement Factor H–Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment

Circulating complement factor H–related protein 5 levels contribute to development and progression of IgA nephropathy

Complement and kidney disease, new insights

Can Urinary Complement Proteins Stratify Patients to Therapeutic Complement Inhibitors?

Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis

Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence

Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis

Cohort Study of Outpatient Hemodialysis Management Strategies for COVID-19 in North-West London

Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome

Complement in IgA Nephropathy: The Role of Complement in the Pathogenesis, Diagnosis, and Future Management of IgA Nephropathy

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis

The role of complement in IgA nephropathy

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

5514 IGA NEPHROPATHY: A REAL-WORLD COMPARISON BETWEEN DISEASE SEVERITY, SYMPTOM BURDEN, AND TREATMENT SATISFACTION REPORTED BY PATIENTS AND NEPHROLOGISTS

Long-Term Outcomes of Patients Treated With Tacrolimus as First Line Therapy for Minimal Change Disease: FR-PO660

Suchergebnisse filtern